Start here if you're new
what it is
AdvanSix makes nylon chemicals and fertilizer ingredients used in cars, electronics, carpets, clothing, fishing nets, and packaging.
how it gets paid
Last year Advansix made -$8M in revenue.
why growth slowed
Revenue fell 25.0% last year. Domestic demand likely weakened as a result of uncertainties regarding trade policies and waning consumer sentiment.
what just happened
The last quarter delivered -$0.11 EPS versus a $0.09 estimate, a 27.78% miss.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
30/100 earnings predictability — expect surprises
9.4x trailing p/e — the market's not buying it — or you found a deal
3.5% dividend yield — cash in your pocket every quarter
7.0% return on capital — nothing to write home about
xvary composite: 57/100 — below average
What they do
AdvanSix makes nylon chemicals and fertilizer ingredients used in cars, electronics, carpets, clothing, fishing nets, and packaging.
AdvanSix wins by not being a one-product hostage. Plant nutrients are 30% of sales, while nylon products are 23%, caprolactam is 18%, and chemical intermediates are 29%, so one weak end market does not wreck your whole year. That mix matters when Europe stays soft, China slows, and farmers still buy the cheaper ammonium sulfate product.
How they make money
-$8M
annual revenue · revenue declined -25.0% last year
total revenue
-$8M
25.0%
The products that matter
engineered plastic resin production
Nylon 6 Polymer
part of 51% of revenue
this is one side of the business under pressure. together with chemical intermediaries, it represents about 51% of total revenue, so weakness here has nowhere to hide.
core volume
raw chemical input manufacturing
Chemical Intermediaries
part of 51% of revenue
these products feed the nylon chain and are part of the same revenue block facing softer demand. the integration helps, but it does not erase end-market weakness.
integrated chain
plant nutrient production
Ammonium Sulphate Fertilizer
about 30% of sales
this segment matters because roughly 30% of sales is big enough to offset some chemicals weakness. the snapshot says farmers leaned toward ASIX's cheaper local product instead of tariff-laden chinese imports.
support segment
Key numbers
9.4x
trailing p/e
P/E ratio → price versus annual profit → so what: you are paying $9.40 for each $1 of trailing earnings, which is cheap if the $2.45 fiscal 2026 EPS estimate holds.
3.5%
dividend yield
Dividend yield → cash paid to shareholders each year → so what: you get paid 3.5% a year while you wait for the chemical cycle to recover.
33%
debt/capital
Debt as a share of capital → how leveraged the balance sheet is → so what: $250M of long-term debt is meaningful, but it is not a balance-sheet emergency.
7.0%
return on capital
Return on capital → profit earned on money invested in the business → so what: 7.0% says this is a cyclical grinder, not a premium compounding machine.
Financial health
B++
strength
- balance sheet grade B++ — above average financial health
- risk rank 3 — safer than 50% of stocks
- price stability 40 / 100
- long-term debt $250M (33% of capital)
- net profit margin 4.9% — keeps 5 cents of every dollar in revenue
- return on equity 8% — $0.08 profit for every $1 investors have put in
B++ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in ASIX 3 years ago → it's now worth $4,890.
The index would have given you $13,880.
source: institutional data · total return
What just happened
missed estimates
The last quarter delivered -$0.11 EPS versus a $0.09 estimate, a 27.78% miss.
That miss matters because the yearly setup still points higher, with fiscal 2025 EPS at $2.00 and fiscal 2026 estimated at $2.45. The quiet part out loud: one bad quarter is normal here, because this business rides commodity pricing.
$6M
revenue
$0.11
eps
27.78%
surprise
the number that mattered
The key number was the 27.78% EPS miss, because it shows how fast this stock can flip from recovery story to cyclical headache.
-
sales have been sliding in the nylon products and chemical intermediaries businesses.
-
these two operations generally account for about 51% of total revenue.domestic demand likely weakened as a result of uncertainties regarding trade policies and waning consumer sentiment.
-
meanwhile, european demand probably stayed soft, and chinese economic growth has been waning.
-
the plant nutrients segment (about 30% of sales) likely fared well as the farming sector bought asix’s cheaper ammonium sulphate fertilizers, rather than tariff-laden chinese imports.the bottom line is always more unpredictable, but omitting any unplanned operational outages, advansix likely posted a meager profit.
-
we don’t foresee any sales growth in 2026.advansix is a small fish in a big pond, and that pond (specialty chemicals) is not expected to grow much this year. advansix has been absorbing many of its imported raw material tariffs, but will probably have to pass them on to its clients in the form of higher prices in 2026.
source: wall street consensus, latest reported quarter
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the top risk is continued weakness in nylon products and chemical intermediaries.
med
51% of revenue is in the pressure zone
nylon products and chemical intermediaries generally make up about 51% of total revenue, and both have been sliding.
if those lines do not stabilize, the stock stays cheap for a reason.
med
end markets are not helping
the snapshot points to trade-policy uncertainty, weaker consumer sentiment, soft european demand, and slower chinese growth.
this is a cyclical materials business. when demand softens across regions, volume and pricing usually soften with it.
med
tariffs can turn into margin pressure fast
ASIX has been absorbing tariffs on imported raw materials and may have to pass those costs through in 2026.
if customers resist higher prices, the 4.4% net margin does not leave much cushion.
med
the feed itself is noisy
this page shows -$8M annual revenue, -$2M quarterly revenue, and a separate $1B revenue estimate for fy2026.
when the inputs conflict, you should lean more heavily on management commentary, segment trends, and future filings than on any single top-line figure here.
between the 51% of revenue tied to nylon products plus chemical intermediaries and the 30% tied to plant nutrients, a handful of commodity-sensitive markets control most of the story.
source: institutional data · regulatory filings · risk analysis
Pay attention to
trend
stabilization in the 51% revenue bucket
nylon products and chemical intermediaries are the key read-through. if those lines stop shrinking, the value case gets a lot more believable.
metric
fy2026 revenue versus the $1B estimate
the page shows conflicting top-line data. any clean confirmation around the $1B revenue estimate would make the rest of the model easier to trust.
risk
cost pass-through on imported raw materials
if ASIX has to raise prices to protect margins, you want to see whether customers absorb it or volumes crack further.
calendar
next quarterly print
this is the next reality check on demand, dividend coverage, and whether the ugly quarterly numbers on this page were a one-off or the new normal.
Analyst rankings
short-term outlook
average
momentum score 3 — in human-speak, analysts see a stock behaving like the market, not one with a strong near-term edge.
risk profile
average
stability score 3 means typical balance-sheet risk. not especially safe, not a disaster either.
chart momentum
below average
technical score 4 says price action is not doing you any favors right now.
earnings predictability
30 / 100
low predictability means the quarterly path can look messy even when the full-year number looks fine.
source: institutional data
Institutional activity
institutions have been net buying for 2 consecutive quarters — 116 buyers vs. 113 sellers in 3q2025. total institutional holdings: 24.6M shares. net buying for 2 quarters.
source: institutional data
Price targets
3-5 year target range
$16
$42
$19
current price
$29
target midpoint · +54% from current · 3-5yr high: $35 (+85% · 19% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive